NCT04628767 2026-03-18
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
National Cancer Institute (NCI)
Phase 2/3 Recruiting
Clinical Trials
1 trialsRenal Pelvis and Ureter Urothelial Carcinoma × pegylated granulocyte colony-stimulating factor × 90 days × Clear all